BioPharma Sol - Research Devel
Biological
Baxter Healthcare
Total Payments
$2.5M
Transactions
36
Doctors
13
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $1.3M | 10 | 0 |
| 2019 | $1.3M | 26 | 13 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.5M | 15 | 97.6% |
| Consulting Fee | $45,042 | 19 | 1.8% |
| Education | $16,772 | 2 | 0.7% |
Payments by Type
Research
$2.5M
15 transactions
General
$61,813
21 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Bioequivalence Study Assessing a Single Dose of Iron Sucrose Injection -Baxter- or a Single Dose of Venofer Injection in Healthy Adult Subjects | Baxter Healthcare | $2.5M | 0 |
Top Doctors Receiving Payments for BioPharma Sol - Research Devel
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Skokie, IL | $2.5M | 22 |
| , M.D., F.A.C.P.E | Medical Oncology | Minneapolis, MN | $400.00 | 1 |
| Kenneth Hoffman | — | Teaneck, NJ | $400.00 | 1 |
| , M.D./PH.D | Internal Medicine | Scottsdale, AZ | $400.00 | 1 |
| , M.D | Anesthesiology | New York, NY | $375.00 | 2 |
| , MD | Hematology & Oncology | Puyallup, WA | $350.00 | 1 |
| , M.D | Anesthesiology | Rochester, MN | $350.00 | 1 |
| , MD | Interventional Cardiology | Blue Bell, PA | $300.00 | 1 |
| , M.D | Internal Medicine | Philadelphia, PA | $300.00 | 1 |
| , MD | Pediatric Hematology-Oncology | Mangonia Park, FL | $300.00 | 1 |
| , M.D | Nephrology | Bend, OR | $300.00 | 1 |
| , M.D | Surgery | Mentor, OH | $300.00 | 1 |
| , M.B.B.S., MPH | Hospitalist | Newport News, VA | $210.00 | 1 |
| , MD | Internal Medicine | Dallas, TX | $125.00 | 1 |
Ad
Manufacturing Companies
- Baxter Healthcare $2.5M
- BAXTER HEALTHCARE $45,042
Product Information
- Type Biological
- Total Payments $2.5M
- Total Doctors 13
- Transactions 36
About BioPharma Sol - Research Devel
BioPharma Sol - Research Devel is a biological associated with $2.5M in payments to 13 healthcare providers, recorded across 36 transactions in the CMS Open Payments database. The primary manufacturer is Baxter Healthcare.
Payment data is available from 2019 to 2020. In 2020, $1.3M was paid across 10 transactions to 0 doctors.
The most common payment nature for BioPharma Sol - Research Devel is "Unspecified" ($2.5M, 97.6% of total).
BioPharma Sol - Research Devel is associated with 1 research study, including "Bioequivalence Study Assessing a Single Dose of Iron Sucrose Injection -Baxter- or a Single Dose of Venofer Injection in Healthy Adult Subjects" ($2.5M).